发明艾滋病新药免费救治征集媒体见证人
从1985年中国发现了第一例患者至今,国内外艾滋病严峻的发展局势,已经严重影响了人们的健康生活。
发明人在此严重申明∶不为名誉,只为患者;因为现在还有不少因西药副作用、抗药性导致的病痛继续。
一个自1993年至今一直在艾滋病领域研究中药防治技术的人。
一个一直以来接触、并努力研究、已经研究成功,并将新药研究做到化学成分阶段;也经过免疫实验初步证实∶却因HIV体内、体外试验没有经费而决定用药物来“说话”的人,寻求媒体关注、参与这个公益性事业的完善。
他的决定是这样的∶在媒体的报道下,与征集的〔必须的〕100名患者〔患者好征集〕签署服药协议,观测前后治疗变化,免费提供药品,观察一定时间药品的疗效,以期待新药疗效得到验证或者投资商投资;真正造福患者。
发明人清楚新药试用患者必须国家药品监督机构批准,为了社会公益事业的发展;更愿意配合国家开展这个工作的申请。
据发明人介绍∶所发明的新药来源于食品特殊萃取有效营养、功效成分,作用独特、科学标准;生物性抑制HIV病毒毒癍的形成并提升患者T淋巴细胞CD4数目调节免疫,治疗艾滋病,没有任何副作用;费用低廉、安全适应性强,适合中国以及发展中国家普及推广。
征集媒体具备追踪报道、行业分析、社会关注以及其他促进这个行业与传播艾滋病防治知识的允许。
联系∶15809294481 15991002739
E-maiil∶huizhongyiliao@tom.com
所有关注这个事件进展的媒体与记者,请先电话预约;谢绝直接采访,最终确定参与媒体与记者。
From China in 1985 patients found that the first date, both at home and abroad to develop a severe AIDS situation has seriously affected the lives of people's health.
In this serious inventors stated that: the reputation of not only the patient; because there are many Western medicines due to side effects caused by drug-resistant diseases to continue.
One since 1993 has been research in the field of AIDS prevention and control skills of Chinese medicine.
Has always been a contact, and research efforts have been successful and will be the chemical constituents of New Drug Research stage; also confirmed that after the initial immunization experiments: because of HIV in vivo, in vitro test to determine there are no funds to use drugs, "person", seek media attention, involved in the improvement of public welfare.
His decision is this: in the media with collecting the necessary 〔〕 〔100 patients with a good collection in patients with medication〕 signed agreement, the changes observed before and after the treatment, free drugs, a certain period of time to observe the efficacy of drugs in order to look forward to proven efficacy of new drugs or investors investment; can bring real benefits to patients.
The inventor must be clearly drug trial in patients with the approval of the national drug monitoring body, in order to cause the development of social welfare; more willing to work with the countries of this application.
According to the inventor, introduced: the invention of new drugs effective extraction from special food nutrition, efficacy of ingredients, the role of a unique, scientific standards; biological癍drugs inhibit HIV virus and enhance the formation of T lymphocytes in patients with the number of CD4 immune regulation, the treatment of AIDS, there is no any side-effects; low-cost, security, adaptability, suitable for China and developing countries to promote universal access.
Call for media with follow-up reports, industry analysis, social concerns, as well as other industries to promote the dissemination of AIDS knowledge and permission.
Contact: 15809294481 15991002739
E-maiil: huizhongyiliao@tom.com
Concerned about the progress of this incident all the media and press, please telephone appointment; declined a direct interview, and ultimately determine the involvement of the media and journalists.
艾滋病免疫重建的重要意义是挽救生命的根本 点击 213
从食品植物研究开发的治疗艾滋病新药三合皂甙〔康生丹四代〕介绍 点击 567
从食品植物研究开发的治疗艾滋病新药三合皂甙 点击 245
从食品植物研究开发的治疗艾滋病新药介绍 点击 189
艾滋病的中药 点击 56
论HIV不是AIDS的病因机制 点击 78
康生丹颗粒简介 点击 67
美国营养学家推崇“抗炎饮食”同于中医之食疗 点击 123
康生丹颗粒基础研究 点击 59
艾滋病预防及国外食疗研究 点击 61
艾滋病感染者能活多久 点击 232
专家:艾滋病早治疗能多活30年以上“隐形”感染者进入晚期才被确诊 点击 99
T细胞、T细胞亚群、 调节性(或抑制性)T细胞在艾滋病康复中的研究 点击 89
你知道为什么害怕“艾滋病”这三个字么?艾滋病不同感染期症状 点击 1118
康生丹颗粒〈ksd〉对免疫抑制模型小鼠免疫功能影响实验研究-公布 点击 27
食疗与艾滋病研究-康生丹颗粒〈一〉 点击 159
艾滋病未来康复的动向分析 点击 227
艾滋病人的药膳 点击 43
首次公布康生丹提高艾滋病患者CD4的图片 点击 1379